L03.03 * PHASE I CLINICAL AND PHARMACOLOGICAL STUDY OF...

Annals of Oncology 2013 / 03 Vol. 24; Iss. suppl 1

L03.03 * PHASE I CLINICAL AND PHARMACOLOGICAL STUDY OF CETUGEX, A NOVEL ANTI-EGFR MONOCLONAL ANTIBODY WITH AN OPTIMIZED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY

de Dosso, S., Fiedler, W., Gianni, L., Cresta, S., Schulze-Bergkamen, H. B., Gurrieri, L., Salzberg, M., Dietrich, B., Danielczyk, A., Baumeister, H., Goletz, S., Sessa, C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
24
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdt042.10
Date:
March, 2013
File:
PDF, 30 KB
english, 2013
Conversion to is in progress
Conversion to is failed